title: [Seroprevalence of markers of viral hepatitis A, B and C in hospital personnel at the Clermont-Ferrand University Hospital Center].
abstract: OBJECTIVE
  Evaluate risk of hepatitis A, B and C infection and anti HBV vaccination policy in hospital personnel.
  
  
  METHODS
  A sample of 440 health care workers (7.5% of the personnel at the Clermont-Ferrand University Hospital) representing 74.5% people directly involved in health care and 25.5% other workers were selected at random and stratified by work classification and age. A questionnaire was used to establish personal data on viral hepatitis status and blood samples were drawn for serological tests.
  
  
  RESULTS
  Seroprevalence for hepatitis A was 52% with no significant difference between health care and other workers. For hepatitis B, 88.3% of the population had been vaccinated and anti-HBs titre was > or = 10 mIU/ml for 91.6% and > or = 50 mIU/ml for 86.1%. Seroprevalence for anti-HBc was 7% and none of the subjects were positive for HBs antigen. Anti-hepatic C antibodies were found in 2 health care workers (0.7%).
  
  
  CONCLUSIONS
  These findings emphasize the need to persue further preventive actions against hepatitis A, B and C and the requirement for continued efforts in elementary hygiene.
authors.affiliation: Service de Médecine du Travail et des Maladies professionnelles du CHU de Clermont-Ferrand.
authors.forename: K
authors.initials: K
authors.lastname: Djeriri
authors.forename: L
authors.initials: L
authors.lastname: Fontana
authors.forename: H
authors.initials: H
authors.lastname: Laurichesse
authors.forename: H
authors.initials: H
authors.lastname: Peigue-Lafeuille
authors.forename: C
authors.initials: C
authors.lastname: Henquell
authors.forename: A
authors.initials: A
authors.lastname: Chamoux
authors.forename: J
authors.initials: J
authors.lastname: Beytout
authors.forename: P
authors.initials: P
authors.lastname: Catilina
authors.forename: M
authors.initials: M
authors.lastname: Rey
mesh_terms: D000328:Adult; D000367:Age Factors; D005260:Female; D005602:France / Q000453:epidemiology; D006506:Hepatitis A / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control; D006508:Hepatitis Antibodies / Q000032:analysis; D006509:Hepatitis B / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control; D006510:Hepatitis B Antibodies / Q000032:analysis; D006526:Hepatitis C / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control; D018937:Hepatitis C Antibodies / Q000032:analysis; D006785:Hospitals, University; D006801:Humans; D007124:Immunoenzyme Techniques; D008297:Male; D008875:Middle Aged; D016273:Occupational Exposure / Q000517:prevention & control*; D010564:Personnel, Hospital; D015995:Prevalence; D012307:Risk Factors
chemical_list: D006508:Hepatitis Antibodies; D006510:Hepatitis B Antibodies; D018937:Hepatitis C Antibodies
vernacular_title: Séroprévalence des marqueurs des hépatites virales A, B et C, parmi le personnel hospitalier du centre hospitalo-universitaire de Clermont-Ferrand.